Mercy General Hospital Acute Care Hospital (Medicare Certified) Location: 4001 J St, Sacramento, California 95819 Ratings: Phone: (916) 453-4453 |
Sutter Medical Center, Sacramento Acute Care Hospital (Medicare Certified) Location: 2825 Capitol Avenue, Sacramento, California 95816 Ratings: Phone: (916) 733-8999 |
Kaiser Foundation Hospital - Sacramento Acute Care Hospital (Medicare Certified) Location: 2025 Morse Avenue, Sacramento, California 95825 Ratings: Phone: (916) 973-5000 |
Methodist Hospital Of Sacramento Acute Care Hospital (Medicare Certified) Location: 7500 Hospital Drive, Sacramento, California 95823 Ratings: Phone: (916) 423-6010 |
University Of California Davis Medical Center Acute Care Hospital (Medicare Certified) Location: 2315 Stockton Boulevard, Sacramento, California 95817 Ratings: Phone: (916) 734-2011 |
Kaiser Foundation Hosp So Sacramento Acute Care Hospital (Medicare Certified) Location: 6600 Bruceville Road, Sacramento, California 95823 Ratings: Phone: (916) 688-2000 |
Shriners Hospitals For Children Northern Calif Childrens Hospital (Medicare Certified) Location: 2425 Stockton Boulevard, Sacramento, California 95817 Ratings:NA Phone: (916) 453-2000 |
Sierra Vista Hospital, Inc Psychiatric Hospital (Medicare Certified) Location: 8001 Bruceville Road, Sacramento, California 95823 Ratings:NA Phone: (916) 423-2000 |
Sutter Center For Psychiatry Psychiatric Hospital (Medicare Certified) Location: 7700 Folsom Blvd, Sacramento, California 95826 Ratings:NA Phone: (916) 386-3000 |
Heritage Oaks Hospital Psychiatric Hospital (Medicare Certified) Location: 4250 Auburn Blvd, Sacramento, California 95841 Ratings:NA Phone: (916) 489-3336 |
News Archive
Methodist Healthcare and Mayo Clinic announced today that Methodist has joined the Mayo Clinic Care Network, a national network of health care providers committed to better serving patients and their families through collaboration.
As the war on HIV/AIDS begins its fourth decade, medical researchers, pharmaceutical manufacturers, patient advocates and government regulators face a new and unexpected scientific challenge: how to demonstrate the safety and efficacy of promising new antiretroviral drugs when the two traditional study designs – the superiority trial and the non-inferiority trial – are no longer useful in showing improvements in both "treatment experienced" patients and those who have never received drug therapy (treatment-naive patients).
Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced results from a first-in-human, multi-center, Phase 1 study of UX001 in patients with hereditary inclusion body myopathy (HIBM) showing that UX001 was well-tolerated with an expected extended release profile on absorption after oral administration
Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp., continues due diligence toward an agreement to help develop a promising new treatment for Traumatic Brain Injury (TBI), concern continues to grow over the troubling incidence of TBI among athletes and soldiers.
› Verified 8 days ago